Status:

UNKNOWN

PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries

Lead Sponsor:

B. Braun Medical SA

Conditions:

Pressure Ulcer

Eligibility:

All Genders

18-100 years

Brief Summary

To assess the safety and performance of Linovera® in the treatment of Category- I pressure ulcers/injuries.

Detailed Description

The aim of this clinical study is to generate further clinical evidence for the use and benefit of Linovera® in the treatment of Category-I PUs. The results of this study will generate further clinica...

Eligibility Criteria

Inclusion

  • Adult patient (≥ 18 years)
  • Patients with at least one Category-I PU/I (remark: follow-up will be done for one ulcer per patient).
  • Provision of voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the EC prior to all evaluations.
  • Patient naïve to Linovera® 2 weeks before visit 1 (only applicable to the area of the skin that will be assessed).
  • Patients which can be potentially followed until their Category-1 pressure ulcer/injury is healed throughout the duration of the study, according to the clinicians opinion.

Exclusion

  • Age \<18 years
  • Known allergies and/or hypersensitivity to any component of Linovera®.
  • Any medical or psychological disorder that, in the investigator's opinion, may interfere with the patient's ability to give informed consent and comply with the study procedures.
  • Any planned intervention that, in the investigator opinion, may affect skin condition of the patient (e.g. chemotherapy or radiotherapy).
  • Simultaneous participation in an interventional clinical trial (drugs or medical devices studies).
  • Any other additional topical treatments applied in the area of the skin that will be assessed.

Key Trial Info

Start Date :

November 14 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

95 Patients enrolled

Trial Details

Trial ID

NCT06183086

Start Date

November 14 2023

End Date

December 1 2024

Last Update

December 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario Central de Asturias

Oviedo, Spain